Duc Tran

10PUBLICATIONS
125CO-AUTHORS
Haematological tumoursHaematologyGenomics and transcriptomicsNatural language processingGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 28, 2026
Germline homologous recombination deficiency influences TP53-mutant clonal hematopoiesis fitness during platinum and PARP inhibitor treatment.

|May 21, 2026
Co-occurring clonal hematopoiesis exhibits strong selection and high leukemia risk.

|Mar 12, 2026
CDK4/6 inhibition mitigates chemotherapy-induced expansion of TP53-mutant clonal hematopoiesis.

Irenaeus C C Chan, Pu Zhang, Xiangyu Pan

|Jul 15, 2025
Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy.

Jie Liu, Duc Tran, Liying Xue

|Aug 29, 2024
Social, Behavioral, and Clinical Risk Factors Are Associated with Clonal Hematopoiesis.

Corey D Young, Aubrey K Hubbard, Pedro F Saint-Maurice

|Mar 06, 2024
Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk.

Duc Tran, J Scott Beeler, Jie Liu

Pageof 2

Frequent Collaborators

6 joint publications

Kelly L Bolton

4 joint publications

Irenaeus C C Chan

4 joint publications

Giulia Petrone

4 joint publications

Yin Cao